Liquid Biopsy Advancing Non Invasive Cancer Detection And Precision Diagnostic Technologies
Organizations across the healthcare and life sciences sectors are experiencing a transformative shift driven by advancements in molecular diagnostics and precision medicine. Among these innovations, liquid biopsy has emerged as a groundbreaking technology that enables non-invasive disease detection and monitoring using bodily fluids such as blood. Unlike conventional tissue biopsies, liquid biopsy offers a safer, faster, and more dynamic approach to understanding disease progression, particularly in oncology. Liquid biopsy works by analyzing biomarkers such as circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), and extracellular vesicles. These biomarkers provide valuable insights into genetic mutations, tumor evolution, and treatment response. As a result, clinicians can make more informed decisions without subjecting patients to invasive procedures. Technological advancements in next-generation sequencing (NGS), digital PCR, and bioinformatics are significantly enhan...